DD vs IRD · P/E 127, rev $12.39B vs rev $11.0M
Dupont De Nemours Inc (DD) versus Opus Genetics, Inc. (IRD) — a side-by-side from cached financials, not a winner call.
Dupont De Nemours Inc (DD) is a specialty chemicals company listed on US.
Opus Genetics, Inc. (IRD) is a biotechnology company listed on US.
Latest reported DD revenue for 2024-12-31 was $12.39B. Net income was $738.0M. Revenue was up 2.6% from 2023-12-31 to 2024-12-31. DD currently screens at market cap $19.61B and trailing P/E 127.4.
Latest reported IRD revenue for 2024-12-31 was $11.0M. Net income was -$57.5M. Revenue was down 42.3% from 2023-12-31 to 2024-12-31. IRD currently screens at market cap $35.7M.
DD currently screens at market cap $19.61B and trailing P/E 127.4. IRD currently screens at market cap $35.7M.
Not investment advice. Open the DD and IRD stock pages for the full models.
Not investment advice.